1
|
Habtemariam S. Anti-Inflammatory Therapeutic Mechanisms of Isothiocyanates: Insights from Sulforaphane. Biomedicines 2024; 12:1169. [PMID: 38927376 PMCID: PMC11200786 DOI: 10.3390/biomedicines12061169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2024] [Revised: 05/16/2024] [Accepted: 05/21/2024] [Indexed: 06/28/2024] Open
Abstract
Isothiocyanates (ITCs) belong to a group of natural products that possess a highly reactive electrophilic -N=C=S functional group. They are stored in plants as precursor molecules, glucosinolates, which are processed by the tyrosinase enzyme upon plant tissue damage to release ITCs, along with other products. Isolated from broccoli, sulforaphane is by far the most studied antioxidant ITC, acting primarily through the induction of a transcription factor, the nuclear factor erythroid 2-related factor 2 (Nrf2), which upregulates downstream antioxidant genes/proteins. Paradoxically, sulforaphane, as a pro-oxidant compound, can also increase the levels of reactive oxygen species, a mechanism which is attributed to its anticancer effect. Beyond highlighting the common pro-oxidant and antioxidant effects of sulforaphane, the present paper was designed to assess the diverse anti-inflammatory mechanisms reported to date using a variety of in vitro and in vivo experimental models. Sulforaphane downregulates the expression of pro-inflammatory cytokines, chemokines, adhesion molecules, cycloxyhenase-2, and inducible nitric oxide synthase. The signalling pathways of nuclear factor κB, activator protein 1, sirtuins 1, silent information regulator sirtuin 1 and 3, and microRNAs are among those affected by sulforaphane. These anti-inflammatory actions are sometimes due to direct action via interaction with the sulfhydryl structural moiety of cysteine residues in enzymes/proteins. The following are among the topics discussed in this paper: paradoxical signalling pathways such as the immunosuppressant or immunostimulant mechanisms; crosstalk between the oxidative and inflammatory pathways; and effects dependent on health and disease states.
Collapse
Affiliation(s)
- Solomon Habtemariam
- Pharmacognosy Research & Herbal Analysis Services UK, University of Greenwich, Central Avenue, Chatham-Maritime, Kent ME4 4TB, UK
| |
Collapse
|
2
|
Guo Y, Zhao J, Ma X, Cai M, Chi Y, Sun C, Liu S, Song X, Xu K. Phytochemical reduces toxicity of PM2.5: a review of research progress. Nutr Rev 2024; 82:654-663. [PMID: 37587082 DOI: 10.1093/nutrit/nuad077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/18/2023] Open
Abstract
Studies have shown that exposure to fine particulate matter (PM2.5) affects various cells, systems, and organs in vivo and in vitro. PM2.5 adversely affects human health through mechanisms such as oxidative stress, inflammatory response, autophagy, ferroptosis, and endoplasmic reticulum stress. Phytochemicals are of interest for their broad range of physiological activities and few side effects, and, in recent years, they have been widely used to mitigate the adverse effects caused by PM2.5 exposure. In this review, the roles of various phytochemicals are summarized, including those of polyphenols, carotenoids, organic sulfur compounds, and saponin compounds, in mitigating PM2.5-induced adverse reactions through different molecular mechanisms, including anti-inflammatory and antioxidant mechanisms, inhibition of endoplasmic reticulum stress and ferroptosis, and regulation of autophagy. These are useful as a scientific basis for the prevention and treatment of disease caused by PM2.5.
Collapse
Affiliation(s)
- Yulan Guo
- School of Public Health, Jilin University, Changchun, China
| | - Jinbin Zhao
- School of Public Health, Jilin University, Changchun, China
| | - Xueer Ma
- School of Public Health, Jilin University, Changchun, China
| | - Ming Cai
- School of Public Health, Jilin University, Changchun, China
| | - Yuyang Chi
- School of Public Health, Jilin University, Changchun, China
| | - Chunmeng Sun
- School of Public Health, Jilin University, Changchun, China
| | - Shitong Liu
- School of Public Health, Jilin University, Changchun, China
| | - Xiuling Song
- School of Public Health, Jilin University, Changchun, China
| | - Kun Xu
- School of Medicine, Hunan Normal University, Changsha, China
- The Research Center of Reproduction and Translational Medicine of Hunan Province, Changsha, China
| |
Collapse
|
3
|
Lee EJ, Lee S, Jang HJ, Yoo W. Loliolide in Sargassum horneri Alleviates Ultrafine Urban Particulate Matter (PM 0.1)-Induced Inflammation in Human RPE Cells. Int J Mol Sci 2023; 25:162. [PMID: 38203333 PMCID: PMC10779059 DOI: 10.3390/ijms25010162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2023] [Revised: 12/18/2023] [Accepted: 12/20/2023] [Indexed: 01/12/2024] Open
Abstract
Owing to increasing air pollution due to industrial development, fine dust has been associated with threatening public health. In particular, ultrafine urban particulate matter (uf-UP, PM 0.1) can easily enter our bodies, causing inflammation-related diseases. Therefore, in the present study, we evaluated the effects of hydrothermal extracts of Sargassum horneri and its bioactive compound, loliolide, on uf-UP-induced inflammation as a potential treatment strategy for retinal disorders. Human retinal pigment epithelial cells (ARPE-19) stimulated with TNF-α or uf-UPs were treated with S. horneri extract and loliolide. S. horneri extracts exhibited anti-inflammatory effects on uf-UP-induced inflammation without cell toxicity through downregulating the mRNA expression of MCP-1, IL-8, IL-6, and TNF-α. UPLC-QTOF/MS analysis confirmed that the hydrothermal extract of S. horneri contained loliolide, which has anti-inflammatory effects. Loliolide effectively reduced the mRNA expression and production of proinflammatory chemokines (IL-8) and cytokines (IL-1β and IL-6) by downregulating the MAPK/NF-ĸB signaling pathway on TNF-α-stimulated inflammatory ARPE-19 cells. These effects were further confirmed in inflammatory ARPE-19 cells after stimulation with uf-UPs. Collectively, these results suggested the application of S. horneri as a functional ingredient for treating ocular disorders caused by particular matters.
Collapse
Affiliation(s)
- Eun Jeoung Lee
- AceBiome Inc., Seoul 06164, Republic of Korea; (E.J.L.); (S.L.)
- R&D Center, AceBiome Inc., Daejeon 34013, Republic of Korea
| | - Sol Lee
- AceBiome Inc., Seoul 06164, Republic of Korea; (E.J.L.); (S.L.)
- R&D Center, AceBiome Inc., Daejeon 34013, Republic of Korea
| | - Hyun-Jae Jang
- Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheonju-si 28116, Republic of Korea;
- Natural Product Central Bank, Korea Research Institute of Bioscience and Biotechnology, Cheonju-si 28116, Republic of Korea
| | - Wonbeak Yoo
- Personalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea
| |
Collapse
|
4
|
Kwa FAA, Bui BV, Thompson BR, Ayton LN. Preclinical investigations on broccoli-derived sulforaphane for the treatment of ophthalmic disease. Drug Discov Today 2023; 28:103718. [PMID: 37467881 DOI: 10.1016/j.drudis.2023.103718] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2022] [Revised: 07/04/2023] [Accepted: 07/12/2023] [Indexed: 07/21/2023]
Abstract
Vision loss causes a significant burden on individuals and communities on a financial, emotional and social level. Common causes include age-related macular degeneration (AMD), diabetic retinopathy (DR), glaucoma and retinitis pigmentosa (RP; also known as 'rod-cone dystrophy'). As the population continues to grow and age globally, an increasing number of people will experience vision loss. Hence, there is an urgent need to develop therapies that can curb early pathological events. The broccoli-derived compound, sulforaphane (SFN), is reported to have multiple health benefits and modes of action. In this review, we outline the preclinical findings on SFN in ocular diseases and discuss the future clinical testing of this compound.
Collapse
Affiliation(s)
- Faith A A Kwa
- Department of Health Sciences and Biostatistics, School of Health Sciences, Swinburne University of Technology, Hawthorn, VIC 3122, Australia.
| | - Bang V Bui
- Department of Optometry & Vision Sciences, Faculty Medicine, Dentistry & Health Sciences, The University of Melbourne, VIC 3010, Australia
| | - Bruce R Thompson
- School of Health Sciences, Faculty Medicine, Dentistry & Health Sciences, The University of Melbourne, VIC 3010, Australia
| | - Lauren N Ayton
- Department of Optometry & Vision Sciences, Faculty Medicine, Dentistry & Health Sciences, The University of Melbourne, VIC 3010, Australia; Department of Surgery (Ophthalmology), Faculty Medicine, Dentistry & Health Sciences, The University of Melbourne, VIC 3010, Australia; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC 3002, Australia
| |
Collapse
|
5
|
Song H, Wang YH, Zhou HY, Cui KM. Sulforaphane alleviates LPS-induced inflammatory injury in ARPE-19 cells by repressing the PWRN2/NF-kB pathway. Immunopharmacol Immunotoxicol 2022; 44:868-876. [PMID: 35766158 DOI: 10.1080/08923973.2022.2090954] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
BACKGROUND Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly population and its pathogenesis has been associated with inflammatory damage to retinal pigment epithelial (RPE) cells. Here, we explored the ability of sulforaphane to protect ARPE-19 cells from lipopolysaccharide (LPS)-induced inflammatory injury and elucidated the underlying molecular mechanism. METHODS Cell viability, apoptosis, inflammation, PWRN2 expression, nuclear transcription factor-kappa B (NF-kB) activity, and the interaction between PWRN2 and the IkBa protein were assessed in RPE cells under- or over-expressing PWRN2 that had been treated with LPS and sulforaphane. RESULTS Overexpression of PWRN2 in LPS-treated cells promoted NF-kB activation by interacting with IkBa, thus reducing cell viability. In contrast, PWRN2 downregulation repressed LPS-induced NF-kB activation and apoptosis in RPE cells. Similarly, sulforaphane downregulated PWRN2 and inhibited NF-kB activation in a concentration-dependent manner. Conversely, PWRN2 overexpression or NF-kB upregulation weakened the anti-inflammatory effects of sulforaphane. CONCLUSION Our results suggest that sulforaphane protects RPE cells from LPS-induced inflammatory injury by suppressing the PWRN2/NF-kB pathway.
Collapse
Affiliation(s)
- Hui Song
- Eye Center, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, P.R. China
| | - Ying-Hao Wang
- Eye Center, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, P.R. China
| | - Hai-Yan Zhou
- Eye Center, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, P.R. China
| | - Kun-Ming Cui
- Eye Center, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, P.R. China
| |
Collapse
|
6
|
Wang S, Tang YJ. Sulforaphane ameliorates amyloid-β-induced inflammatory injury by suppressing the PARP1/SIRT1 pathway in retinal pigment epithelial cells. Bioengineered 2021; 12:7079-7089. [PMID: 34982643 PMCID: PMC8973853 DOI: 10.1080/21655979.2021.1976503] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
Age-associated macular degeneration (AMD) is a progressive eye disorder that leads to irreversible impairment of central vision, and effective therapies are lacking. Here, we explore how oligomeric amyloid-β1-42 can trigger inflammatory injury in retinal pigment epithelial cells and how sulforaphane can mitigate such injury. ARPE-19 retinal pigment epithelial cells expressing low, endogenous, or high levels of poly(ADP-ribose) polymerase (PARP1) were treated with oligomeric amyloid-β1-42 in the presence or absence of various signaling inhibitors or sulforaphane. Cell viability, apoptosis, inflammatory responses, and activity of the PARP1/Sirtuin (SIRT1) axis were assayed. Treating ARPE-19 cells with oligomeric amyloid-β1-42 promoted the production of IL-1β, IL-6, IL-8, and TNF-ɑ, which was partially reversed by inhibiting PARP1 and activating SIRT1. PARP1 was found to act upstream of SIRT1, and expression of the two proteins correlated negatively with each other. Sulforaphane also mitigated the injury due to oligomeric amyloid-β1-42 through a mechanism involving inactivation of the PARP1/SIRT1 pathway. Oligomeric amyloid-β1-42 can trigger AMD-like injury in retinal pigment epithelium by activating PARP1 and repressing SIRT1. Moreover, sulforaphane can induce cell viability and SIRT1 expression, but reduce cell apoptosis, the activity of caspase-3 or -9, and PARP1 expression in oAβ1-42-treated cells. However, PARP1 inactivation or SIRT1 activation weaken these effects. In summary, sulforaphane reduces the inflammatory injury induced by oAβ1-42 in ARPE-19 cell by inactivating the PARP1/SIRT1 pathway. Thus, the compound may be an effective therapy against AMD.
Collapse
Affiliation(s)
- Song Wang
- Department of Pharmacy, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China
| | - Yu-Jie Tang
- Department of Pharmacy, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China
| |
Collapse
|
7
|
Choi JY, Bae JE, Kim JB, Jo DS, Park NY, Kim YH, Lee HJ, Kim SH, Kim SH, Jeon HB, Na HW, Choi H, Ryu HY, Ryoo ZY, Lee HS, Cho DH. 2-IPMA Ameliorates PM2.5-Induced Inflammation by Promoting Primary Ciliogenesis in RPE Cells. Molecules 2021; 26:molecules26175409. [PMID: 34500843 PMCID: PMC8433925 DOI: 10.3390/molecules26175409] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2021] [Revised: 08/31/2021] [Accepted: 09/01/2021] [Indexed: 12/22/2022] Open
Abstract
Primary cilia mediate the interactions between cells and external stresses. Thus, dysregulation of primary cilia is implicated in various ciliopathies, e.g., degeneration of the retina caused by dysregulation of the photoreceptor primary cilium. Particulate matter (PM) can cause epithelium injury and endothelial dysfunction by increasing oxidative stress and inflammatory responses. Previously, we showed that PM disrupts the formation of primary cilia in retinal pigment epithelium (RPE) cells. In the present study, we identified 2-isopropylmalic acid (2-IPMA) as a novel inducer of primary ciliogenesis from a metabolite library screening. Both ciliated cells and primary cilium length were increased in 2-IPMA-treated RPE cells. Notably, 2-IPMA strongly promoted primary ciliogenesis and restored PM2.5-induced dysgenesis of primary cilia in RPE cells. Both excessive reactive oxygen species (ROS) generation and activation of a stress kinase, JNK, by PM2.5 were reduced by 2-IPMA. Moreover, 2-IPMA inhibited proinflammatory cytokine production, i.e., IL-6 and TNF-α, induced by PM2.5 in RPE cells. Taken together, our data suggest that 2-IPMA ameliorates PM2.5-induced inflammation by promoting primary ciliogenesis in RPE cells.
Collapse
Affiliation(s)
- Ji Yeon Choi
- BK21 FOUR KNU Creative BioResearch Group, School of Life Sciences, Kyungpook National University, Daegu 41566, Korea; (J.Y.C.); (J.B.K.); (D.S.J.); (N.Y.P.); (Y.H.K.); (H.J.L.); (S.H.K.); (S.H.K.); (H.-Y.R.); (Z.Y.R.); (H.-S.L.)
| | - Ji-Eun Bae
- Brain Science and Engineering Institute, Kyungpook National University, Daegu 41566, Korea;
| | - Joon Bum Kim
- BK21 FOUR KNU Creative BioResearch Group, School of Life Sciences, Kyungpook National University, Daegu 41566, Korea; (J.Y.C.); (J.B.K.); (D.S.J.); (N.Y.P.); (Y.H.K.); (H.J.L.); (S.H.K.); (S.H.K.); (H.-Y.R.); (Z.Y.R.); (H.-S.L.)
| | - Doo Sin Jo
- BK21 FOUR KNU Creative BioResearch Group, School of Life Sciences, Kyungpook National University, Daegu 41566, Korea; (J.Y.C.); (J.B.K.); (D.S.J.); (N.Y.P.); (Y.H.K.); (H.J.L.); (S.H.K.); (S.H.K.); (H.-Y.R.); (Z.Y.R.); (H.-S.L.)
| | - Na Yeon Park
- BK21 FOUR KNU Creative BioResearch Group, School of Life Sciences, Kyungpook National University, Daegu 41566, Korea; (J.Y.C.); (J.B.K.); (D.S.J.); (N.Y.P.); (Y.H.K.); (H.J.L.); (S.H.K.); (S.H.K.); (H.-Y.R.); (Z.Y.R.); (H.-S.L.)
| | - Yong Hwan Kim
- BK21 FOUR KNU Creative BioResearch Group, School of Life Sciences, Kyungpook National University, Daegu 41566, Korea; (J.Y.C.); (J.B.K.); (D.S.J.); (N.Y.P.); (Y.H.K.); (H.J.L.); (S.H.K.); (S.H.K.); (H.-Y.R.); (Z.Y.R.); (H.-S.L.)
| | - Ha Jung Lee
- BK21 FOUR KNU Creative BioResearch Group, School of Life Sciences, Kyungpook National University, Daegu 41566, Korea; (J.Y.C.); (J.B.K.); (D.S.J.); (N.Y.P.); (Y.H.K.); (H.J.L.); (S.H.K.); (S.H.K.); (H.-Y.R.); (Z.Y.R.); (H.-S.L.)
| | - Seong Hyun Kim
- BK21 FOUR KNU Creative BioResearch Group, School of Life Sciences, Kyungpook National University, Daegu 41566, Korea; (J.Y.C.); (J.B.K.); (D.S.J.); (N.Y.P.); (Y.H.K.); (H.J.L.); (S.H.K.); (S.H.K.); (H.-Y.R.); (Z.Y.R.); (H.-S.L.)
| | - So Hyun Kim
- BK21 FOUR KNU Creative BioResearch Group, School of Life Sciences, Kyungpook National University, Daegu 41566, Korea; (J.Y.C.); (J.B.K.); (D.S.J.); (N.Y.P.); (Y.H.K.); (H.J.L.); (S.H.K.); (S.H.K.); (H.-Y.R.); (Z.Y.R.); (H.-S.L.)
| | - Hong Bae Jeon
- Stem Cell Institute, ENCell Co. Ltd., Seoul 06072, Korea;
| | - Hye-Won Na
- R&D Center AMOREPACIFIC Corporation, Yongin 17074, Gyeonggi-do, Korea; (H.-W.N.); (H.C.)
| | - Hyungjung Choi
- R&D Center AMOREPACIFIC Corporation, Yongin 17074, Gyeonggi-do, Korea; (H.-W.N.); (H.C.)
| | - Hong-Yeoul Ryu
- BK21 FOUR KNU Creative BioResearch Group, School of Life Sciences, Kyungpook National University, Daegu 41566, Korea; (J.Y.C.); (J.B.K.); (D.S.J.); (N.Y.P.); (Y.H.K.); (H.J.L.); (S.H.K.); (S.H.K.); (H.-Y.R.); (Z.Y.R.); (H.-S.L.)
| | - Zae Young Ryoo
- BK21 FOUR KNU Creative BioResearch Group, School of Life Sciences, Kyungpook National University, Daegu 41566, Korea; (J.Y.C.); (J.B.K.); (D.S.J.); (N.Y.P.); (Y.H.K.); (H.J.L.); (S.H.K.); (S.H.K.); (H.-Y.R.); (Z.Y.R.); (H.-S.L.)
| | - Hyun-Shik Lee
- BK21 FOUR KNU Creative BioResearch Group, School of Life Sciences, Kyungpook National University, Daegu 41566, Korea; (J.Y.C.); (J.B.K.); (D.S.J.); (N.Y.P.); (Y.H.K.); (H.J.L.); (S.H.K.); (S.H.K.); (H.-Y.R.); (Z.Y.R.); (H.-S.L.)
| | - Dong-Hyung Cho
- BK21 FOUR KNU Creative BioResearch Group, School of Life Sciences, Kyungpook National University, Daegu 41566, Korea; (J.Y.C.); (J.B.K.); (D.S.J.); (N.Y.P.); (Y.H.K.); (H.J.L.); (S.H.K.); (S.H.K.); (H.-Y.R.); (Z.Y.R.); (H.-S.L.)
- Brain Science and Engineering Institute, Kyungpook National University, Daegu 41566, Korea;
- Correspondence:
| |
Collapse
|